目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing prevalence of cardiovascular diseases
3.3.1.2. Technological advancements
3.3.1.3. Aging population
3.3.2. Market restraint analysis
3.3.2.1. Regulatory challenges
3.3.2.2. High cost of development
3.4. Cardiovascular Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Pipeline Analysis

Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis
4.1. Cardiovascular Devices Market: Product Key Takeaways
4.2. Cardiovascular Devices Market: Product Movement & Market Share Analysis, 2024 & 2033
4.3. Diagnostic and Monitoring Devices
4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.1. ECG
4.3.1.1.1. ECG market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.2. Implantable Cardiac Monitors
4.3.1.2.1. Implantable cardiac monitors market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.3. Holter Monitors
4.3.1.3.1. Holter monitors market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.4. Mobile Cardiac Telemetry
4.3.1.4.1. Mobile cardiac telemetry market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.5. MRI
4.3.1.5.1. MRI estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6. Cardiovascular Ultrasound
4.3.1.6.1. Cardiovascular ultrasound market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6.2. 2D
4.3.1.6.2.1. 2D market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6.3. 3D/4D
4.3.1.6.3.1. 3D/4D market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.6.4. Doppler
4.3.1.6.4.1. Doppler market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.7. Cardiac Diagnostic Catheters
4.3.1.7.1. Cardiac diagnostic catheters market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.1.8. PET Scanner
4.3.1.8.1. PET scanner market estimates and forecasts, 2021 to 2033 (USD Million)
4.4. Surgical Devices
4.4.1. Surgical devices market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.1. Cardiac Resynchronization Therapy (CRT)
4.4.1.1.1. Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.1.2. CRT-Defibrillator
4.4.1.1.2.1. CRT-defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.1.3. CRT-Pacemaker
4.4.1.1.3.1. CRT-pacemaker market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.2. Implantable Cardioverter Defibrillators (ICDs)
4.4.1.2.1. Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.2.2. Single Chamber ICDs
4.4.1.2.2.1. Single chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.2.3. Dual Chamber ICDs
4.4.1.2.3.1. Dual chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.3. Pacemakers
4.4.1.3.1. Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.3.2. Conventional Pacemakers
4.4.1.3.2.1. Conventional pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.3.3. Leadless Pacemakers
4.4.1.3.3.1. Leadless pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.4. Coronary Stents
4.4.1.4.1. Coronary stents market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.5. Catheters
4.4.1.5.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.6. Guidewires
4.4.1.6.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.7. Cannula
4.4.1.7.1. Cannula market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.8. Valves
4.4.1.8.1. Valves market estimates and forecasts, 2021 to 2033 (USD Million)
4.4.1.9. Occlusion devices
4.4.1.9.1. Occlusion devices market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country and Product
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6. Norway
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. India
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Australia
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. Argentina
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. Mexico
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
5.7.3. UAE
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
5.7.4. Kuwait
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2024
6.3. Market Participant Categorization
6.3.1. Abbott
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. GE HealthCare
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Edwards Lifesciences Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. W. L. Gore & Associates, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Siemens Healthcare GmbH
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. BIOTRONIK SE & Co. KG
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Canon Medical Systems Asia Pte. Ltd.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. B. Braun SE
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. LivaNova PLC
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Cardinal Health
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Medtronic
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Boston Scientific Corporation
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 3 North America cardiovascular devices market, by region, 2021 - 2033 (USD Million)
Table 4 U.S. cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 5 Canada cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 6 Mexico cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 7 Europe cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 8 Europe cardiovascular devices market, by region, 2021 - 2033 (USD Million)
Table 9 Germany cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 10 UK cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 11 France cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 12 Italy cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 13 Spain cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 14 Sweden cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 15 Norway cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 16 Denmark cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 17 Asia Pacific cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 18 Asia Pacific cardiovascular devices market, by region, 2021 - 2033 (USD Million)
Table 19 China cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 20 Japan cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 21 India cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 22 Australia cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 23 Thailand cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 24 South Korea cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 25 Latin America cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 26 Latin America cardiovascular devices market, by region, 2021 - 2033 (USD Million)
Table 27 Brazil cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 28 Argentina cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 29 Middle East and Africa cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 30 Middle East and Africa cardiovascular devices market, by region, 2021 - 2033 (USD Million)
Table 31 South Africa cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 32 Saudi Arabia cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 33 UAE cardiovascular devices market, by product, 2021 - 2033 (USD Million)
Table 34 Kuwait cardiovascular devices market, by product, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cardiovascular devices market: Market outlook
Fig. 9 Cardiovascular devices market: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cardiovascular devices market driver impact
Fig. 15 Cardiovascular devices market restraint impact
Fig. 16 Cardiovascular devices market strategic initiatives analysis
Fig. 17 Cardiovascular devices market: Product movement analysis
Fig. 18 Cardiovascular devices market: Product outlook and key takeaways
Fig. 19 Diagnostic and monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 ECG market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Implantable cardiac monitors market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Holter monitors market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Mobile cardiac telemetry market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Cardiovascular ultrasound market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 2D market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 3D/4D market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Doppler market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Cardiac diagnostic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Pet scan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Cardiac CT market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Doppler fetal monitors market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 PET scanner market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Surgical devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 CRT-defibrillator market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 CRT-pacemaker market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Single Chamber ICDs market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Dual Chamber ICDs market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Pacemakers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Conventional pacemakers market estimates and forecasts, 2021 - 2033 (USD Million
Fig. 44 Leadless pacemaker market estimates and forecasts, 2021 - 2033 (USD Million
Fig. 45 Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Valves market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Occlusion devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Global cardiovascular devices market: Regional movement analysis
Fig. 51 Global cardiovascular devices market: Regional outlook and key takeaways
Fig. 52 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 China market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 Market share of key market players cardiovascular devices market